KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Interest & Investment Income (2017 - 2025)

Twist Bioscience (TWST) has disclosed Interest & Investment Income for 6 consecutive years, with $3.9 million as the latest value for Q3 2023.

  • On a quarterly basis, Interest & Investment Income rose 101.92% to $3.9 million in Q3 2023 year-over-year; TTM through Sep 2023 was $14.4 million, a 369.14% increase, with the full-year FY2025 number at $11.4 million, down 25.94% from a year prior.
  • Interest & Investment Income was $3.9 million for Q3 2023 at Twist Bioscience, down from $4.0 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $4.0 million in Q2 2023 to a low of $58000.0 in Q3 2021.
  • A 5-year average of $1.1 million and a median of $576000.0 in 2020 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: tumbled 85.93% in 2020, then soared 3224.14% in 2022.
  • Twist Bioscience's Interest & Investment Income stood at $564000.0 in 2019, then crashed by 76.24% to $134000.0 in 2020, then grew by 14.93% to $154000.0 in 2021, then skyrocketed by 1874.03% to $3.0 million in 2022, then grew by 28.06% to $3.9 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Interest & Investment Income are $3.9 million (Q3 2023), $4.0 million (Q2 2023), and $3.5 million (Q1 2023).